Our approved medicines

The medicines below have marketing authorizations in the countries listed. Eligible patients may have access to our approved medicines in additional countries, based on specific reimbursement or other access arrangements. For more information, please contact Medical Information.

Trademark
Generic Name
Approved in the Following Countries

ALYFTREK™

vanzacaftor/tezacaftor/deutivacaftor

United Kingdom

United States
Please see full U.S. Prescribing Information, including BOXED WARNING.

CASGEVY®

exagamglogene autotemcel 
(exa-cel)

Bahrain
Canada
European Union
Iceland
Kingdom of Saudi Arabia
Liechtenstein
Norway
United Arab Emirates
United Kingdom
United States

JOURNAVX™

suzetrigine

United States

KAFTRIO® 
in a combination regimen with ivacaftor

ivacaftor/tezacaftor/elexacaftor in combination with ivacaftor

European Union
Iceland
Norway
United Kingdom

KALYDECO®

ivacaftor

Australia
Brazil
Canada
European Union
Iceland
Israel
Liechtenstein
New Zealand
Norway
Oman
Switzerland
United Arab Emirates
United Kingdom
United States

ORKAMBI®

lumacaftor/ivacaftor

Australia
Brazil
Canada
European Union
Iceland
Israel
Liechtenstein
New Zealand
Norway
Russia
Switzerland
United Kingdom
United States

SYMDEKO®

tezacaftor/ivacaftor and ivacaftor

Australia
Brazil
Canada
Israel
Liechtenstein
New Zealand
Switzerland
United States

SYMKEVI® 
in a combination regimen with ivacaftor

tezacaftor/ivacaftor in combination with ivacaftor

European Union
Iceland
Norway
United Kingdom

TRIKAFTA®

elexacaftor/tezacaftor/ivacaftor and ivacaftor

Australia
Brazil
Canada
Chile
Israel
Liechtenstein
New Zealand
Russia
Switzerland
Uruguay
United States

Please see full U.S. Prescribing Information, including BOXED WARNING. 

Show All